Medical applications of synthetic gene circuits and switches

Synthetic biology enables us to create artificial systems using existing biological components, allowing for an exertion of control over the system so that we can further understand how these components interact or bestow them with new capabilities. A multitude of such applications have emerged in r...

Full description

Bibliographic Details
Main Author: Wong, Meng Lai Nicole
Other Authors: Wong, Wilson W.
Language:en_US
Published: 2020
Subjects:
Online Access:https://hdl.handle.net/2144/41028
id ndltd-bu.edu-oai-open.bu.edu-2144-41028
record_format oai_dc
spelling ndltd-bu.edu-oai-open.bu.edu-2144-410282020-05-21T15:01:53Z Medical applications of synthetic gene circuits and switches Wong, Meng Lai Nicole Wong, Wilson W. Biomedical engineering Synthetic biology enables us to create artificial systems using existing biological components, allowing for an exertion of control over the system so that we can further understand how these components interact or bestow them with new capabilities. A multitude of such applications have emerged in recent decades, among them the introduction of protein chimeras and genetic circuits to cells that can be used to accelerate the development of medical treatments and make them safer. T cell immunotherapy is an example of such a technology, and has shown promising results in the treatment of various cancers. However, a persisting obstacle is the inability to control the activity of these engineered cells, as they can become overactive or display off-target activities. We have developed two approaches for controlling T cell activity: a dual small molecule gated ZAP70 switch, and a collection of drug-inducible chimeric antigen receptors (CARs) encompassing the NS3 protease domain. These artificial components allow for increased regulation over T cell therapy and can potentially make T cell therapy safer in the clinic. In addition to improving the safety of clinical treatments, engineered mammalian cells can also act as pathway-sensitive reporters for use in the discovery of gene and drug targets in large-scale screens. However, in traditional compound screens, temporally transient and weak responses may not be detected. Additionally, the decision of what constitutes a “hit” cell population in genome-wide screens can be relatively arbitrary, and thus key target genes could be missed. To address this, a recombinase-based circuit was developed that provides cells with memory, enhanced sensitivity, and an analog-to-digital readout. This reporter facilitates the screening process and enhances both drug and genome-wide screens. 2022-05-18T00:00:00Z 2020-05-19T19:05:13Z 2020 2020-05-19T04:02:53Z Thesis/Dissertation https://hdl.handle.net/2144/41028 0000-0002-4922-5417 en_US Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/
collection NDLTD
language en_US
sources NDLTD
topic Biomedical engineering
spellingShingle Biomedical engineering
Wong, Meng Lai Nicole
Medical applications of synthetic gene circuits and switches
description Synthetic biology enables us to create artificial systems using existing biological components, allowing for an exertion of control over the system so that we can further understand how these components interact or bestow them with new capabilities. A multitude of such applications have emerged in recent decades, among them the introduction of protein chimeras and genetic circuits to cells that can be used to accelerate the development of medical treatments and make them safer. T cell immunotherapy is an example of such a technology, and has shown promising results in the treatment of various cancers. However, a persisting obstacle is the inability to control the activity of these engineered cells, as they can become overactive or display off-target activities. We have developed two approaches for controlling T cell activity: a dual small molecule gated ZAP70 switch, and a collection of drug-inducible chimeric antigen receptors (CARs) encompassing the NS3 protease domain. These artificial components allow for increased regulation over T cell therapy and can potentially make T cell therapy safer in the clinic. In addition to improving the safety of clinical treatments, engineered mammalian cells can also act as pathway-sensitive reporters for use in the discovery of gene and drug targets in large-scale screens. However, in traditional compound screens, temporally transient and weak responses may not be detected. Additionally, the decision of what constitutes a “hit” cell population in genome-wide screens can be relatively arbitrary, and thus key target genes could be missed. To address this, a recombinase-based circuit was developed that provides cells with memory, enhanced sensitivity, and an analog-to-digital readout. This reporter facilitates the screening process and enhances both drug and genome-wide screens. === 2022-05-18T00:00:00Z
author2 Wong, Wilson W.
author_facet Wong, Wilson W.
Wong, Meng Lai Nicole
author Wong, Meng Lai Nicole
author_sort Wong, Meng Lai Nicole
title Medical applications of synthetic gene circuits and switches
title_short Medical applications of synthetic gene circuits and switches
title_full Medical applications of synthetic gene circuits and switches
title_fullStr Medical applications of synthetic gene circuits and switches
title_full_unstemmed Medical applications of synthetic gene circuits and switches
title_sort medical applications of synthetic gene circuits and switches
publishDate 2020
url https://hdl.handle.net/2144/41028
work_keys_str_mv AT wongmenglainicole medicalapplicationsofsyntheticgenecircuitsandswitches
_version_ 1719315230452875264